Business Daily Media

Business Marketing

.

Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China

  • Written by ACN Newswire - Press Releases

Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China

FOSTER CITY, Calif. and HANGZHOU, China and HOUSTON, Texas, Feb 11, 2021 - (ACN Newswire) - Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, and Iterion Therapeutics, Inc., a venture-backed, clinical stage biotechnology company developing novel

Read more //?#

Popular

6 Ways to Become More Productive in your Law Practice

Productivity is all about doing the right things at the right time, which necessitates completing a task in the most effective and efficient way that is possible. Undeniably, while many of us aim to become more productive in our...

Australian small businesses have been targeted by cyberattacks

New Data Reveals Up to 309,000 Australian small businesses say they’ve been targeted by cyberattacks, yet many are forced to cut cybersecurity costs Mastercard partners with 18-year-old ethical hacker to create Cyber Secure i...

Josh Klein Finalist in National Young Entrepreneurs Award

Social Status Founder Announced as Finalist in National Young Entrepreneurs Award The national Young Entrepreneur Awards have been hailed as a key award that has seen hundreds of young entrepreneurs and start-up innovators from...